계명대학교 의학도서관 Repository

수포성 질환 치료를 위해 Azathioprine을 사용 중인 환자에서 발생한 혈구 감소증 3예

Metadata Downloads
Author(s)
정진웅조현재권준일류영욱김성애
Keimyung Author(s)
Ryoo, Young WookKim, Sung Ae
Department
Dept. of Dermatology (피부과학)
Journal Title
대한피부과학회지
Issued Date
2018
Volume
56
Issue
4
Keyword
AzathioprineMyelosuppressionCytopenia
Abstract
Azathioprine is an immunosuppressive drug that has been widely used in dermatology for the treatment of immunobullous diseases. Myelosuppression is the most important side effect and requires close observation of the complete blood cell count. The clinical findings of myelosuppression include general weakness, poor oral intake, nausea, dyspnea, and pallor. It can occur within several weeks to years after initial azathioprine treatment; thus, a weekly full blood count for the first 4 weeks, followed by reduced frequency of monitoring to a minimum of once every 3 months is recommended. If the myelosuppression is not treated properly, it can lead to fever, secondary infection, sepsis, and even death. Herein, we present three educational cases for dermatologists to order to underline the risk of myelosuppression during azathioprine treatment.
Alternative Title
Three Cases of Cytopenia during Azathioprine Treatment for Bullous Disease
Keimyung Author(s)(Kor)
류영욱
김성애
Publisher
School of Medicine (의과대학)
Citation
정진웅 et al. (2018). 수포성 질환 치료를 위해 Azathioprine을 사용 중인 환자에서 발생한 혈구 감소증 3예. 대한피부과학회지, 56(4), 265–268.
Type
Article
ISSN
0494-4739
Source
http://kiss.kstudy.com/thesis/thesis-view.asp?key=3597071
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/41606
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Dermatology (피부과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.